3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Active not recruiting
2
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
31
Melanoma
20
Neoplasms
13
Breast Neoplasms
11
Pancreatic Neoplasms
9
Lung Neoplasms
9
Head and Neck Neoplasms
9
Triple Negative Breast Neoplasms
8
Stomach Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Ovarian Neoplasms
8
Neoplasm Metastasis
8
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Carcinoma, Hepatocellular
6
Prostatic Neoplasms
4
Hodgkin Disease
4
Glioblastoma
4
Carcinoma, Transitional Cell
4
Carcinoma
4
Uterine Cervical Neoplasms
3
Liver Neoplasms
3
Kidney Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Esophageal Neoplasms
3
Adenocarcinoma
3
Small Cell Lung Carcinoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms, Squamous Cell
2
Mesothelioma
2
Interventions
Radiotherapy
3
Cisplatin
2
sapropterin
1
pembrolizumab
1
fludarabine
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Sentinel Lymph Node Biopsy
1
Ritonavir
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Mindfulness
1
Indinavir
1
Gene Rearrangement
1
Gene Expression Profiling
1
Gemcitabine
1
Exercise
1
Electrochemotherapy
1
Drug Therapy
1
Cyclophosphamide
1
Bleomycin
1
Amplified Fragment Length Polymorphism Analysis
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Vulvar Neoplasms
×
pembrolizumab
×
Clear all
NCT05761132
2023-03-09
Apollo
Leiden University Medical Center
Phase 2
Unknown
40 enrolled